Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.31 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175301 | 0.80 | CYP3A4 (0.39) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL2549360 | 0.80 | CYP3A4 (0.39) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL1066639 | 0.80 | MAPT (0.41) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL3788300 | 0.78 | CYP3A4 (0.38) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL3797444 | 0.78 | CYP3A4 (0.38) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL468460 | 0.78 | TSHR (0.44) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL3264767 | 0.78 | CYP3A4 (0.38) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL177943 | 0.78 | CYP3A4 (0.48) | CYP3A4MAPTTSHRCACNA1BAPBA1 | |
| SCHEMBL16553403 | 0.77 | — | — | |
| SCHEMBL216622 | 0.77 | TSHR (0.43) | CYP3A4MAPTTSHRCACNA1BAPBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1365915-A4 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | SURFACE LOGIX INC (US) | 2008-06-25 | — | — | EP | claimed |
| EP-1475415-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SigmaKalon Services B.V. (NL) | 2004-11-10 | — | — | EP | claimed |
| US-6770721-B1 | PATTERNING TRANSFER ELEMENT COMPRISING CROSSLINKED HYDROXYETHYL METHACRYLATE COPOLYMER HAVING ELEVATED AND RECESSED PORTIONS; HIGH THROUGHPUT DRUG SCREENING | SURFACE LOGIX, INC. | 2004-08-03 | — | — | US | claimed |
| EP-1365915-A1 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | Surface Logix, Inc. (US) | 2003-12-03 | — | — | EP | claimed |
| WO-2002036342-A1 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | SURFACE LOGIX, INC. (US) | 2002-05-10 | — | — | WO | claimed |
| US-8153705-B2 | Silyl esters, their use in binder systems and paint compositions and a process for production thereof | SIGMAKALON B.V. (NL) | 2012-04-10 | — | — | US | disclosed |
| US-8148446-B2 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SIGMAKALON B.V. (NL) | 2012-04-03 | — | — | US | disclosed |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | GILLARD MICHEL | 2010-09-30 | — | — | US | disclosed |
| EP-1365915-A4 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | SURFACE LOGIX INC (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20070161722-A1 | Silyl Esters, Their Use in Binder Systems and Paint Compositions and a Process for Production Thereof | SIGMA COATINGS B.V. (NL) | 2007-07-12 | — | — | US | disclosed |
| EP-1620514-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SigmaKalon B.V. (NL) | 2006-02-01 | — | — | EP | disclosed |
| US-20040247912-A1 | Polymer gel contact masks and methods and molds for making same | KIM ENOCH (US) | 2004-12-09 | — | — | US | disclosed |
| WO-2004099326-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SIGMAKALON B.V. (NL) | 2004-11-18 | — | — | WO | disclosed |
| EP-1475415-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SigmaKalon Services B.V. (NL) | 2004-11-10 | — | — | EP | disclosed |
| US-6770721-B1 | PATTERNING TRANSFER ELEMENT COMPRISING CROSSLINKED HYDROXYETHYL METHACRYLATE COPOLYMER HAVING ELEVATED AND RECESSED PORTIONS; HIGH THROUGHPUT DRUG SCREENING | SURFACE LOGIX, INC. | 2004-08-03 | — | — | US | disclosed |
| EP-1365915-A1 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | Surface Logix, Inc. (US) | 2003-12-03 | — | — | EP | disclosed |
| WO-2002036342-A1 | POLYMER GEL CONTACT MASKS AND METHODS AND MOLDS FOR MAKING SAME | SURFACE LOGIX, INC. (US) | 2002-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | LCT, PCMT1, TST | CYP3A4 610/4885MAPT 176/4885TSHR 4814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.